Status
Conditions
Treatments
About
Prosepective,Randomized, controlled study enrolling full termed parturients admitted for vaginal delivery.
At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups:
Full description
Prosepective,Randomized, controlled study enrolling full termed parturients admitted for vaginal delivery.
At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups:
For the first group: 20 ml of 0,375% isobaric Bupivacain solution will be injected bilaterally under ultrasound direct vision.
Concerning the second group, patients will have a continuous injection of 0,125% Bupivacain solution associated to 0,25 mcg of Sufentanil/ml through an epidural catheter in the L3-L4 or L4-L5 intervertebral space.
For the 2 groups, analgesia will be assessed during all the labor period hourly using the Visual Analog pain Score (VAS).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Ben Souissi Asma, As professor; Mhamed Sami Mebazaa, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal